Cat. No. | Product Name | Species | Expression System |
---|---|---|---|
TMPJ-00347 |
PRLR Protein, Mouse, Recombinant (His)
PRLR,PRL-R,Pr |
Mouse | HEK293 Cells |
PRLR Protein, Mouse, Recombinant (His) is expressed in HEK293 mammalian cells with C-6xHis tag. The predicted molecular weight is 33-40 KDa and the accession number is Q08501. | |||
TMPJ-00346 |
PRLR Protein, Mouse, Recombinant (hFc)
Prolactin R,Prlr |
Mouse | HEK293 Cells |
PRLR Protein, Mouse, Recombinant (hFc) is expressed in HEK293 mammalian cells with C-Fc tag. The predicted molecular weight is 62-88 KDa and the accession number is Q08501. | |||
TMPK-00547 |
PRLR Protein, Cynomolgus, Recombinant (His)
Prolactin R,HPRL,MFAB,P<... |
Cynomolgus | HEK293 Cells |
Prolactin receptor (PRLR) is highly expressed in a subset of human breast cancer and prostate cancer, which makes it a potential target for cancer treatment. In clinical trials, the blockade of PRLR was shown to be safe but with poor efficacy. It is therefore urgent to develop new therapies against PRLR target. Bispecific antibodies (BsAbs) could guide immune cells toward tumor cells, and produced remarkable effects in some cancers. PRLR Protein, Cynomolgus, Recombinant (His) is expressed in HEK... | |||
TMPK-01375 |
PRLR Protein, Canine, Recombinant (hFc)
PRL-R,Prolactin R |
Canine | HEK293 Cells |
Prolactin receptor (PRLR) is highly expressed in a subset of human breast cancer and prostate cancer, which makes it a potential target for cancer treatment. In clinical trials, the blockade of PRLR was shown to be safe but with poor efficacy. It is therefore urgent to develop new therapies against PRLR target. Bispecific antibodies (BsAbs) could guide immune cells toward tumor cells, and produced remarkable effects in some cancers. PRLR Protein, Canine, Recombinant (hFc) is expressed in HEK293 ... |